Iskra M, Majewski W
Department of General Chemistry, Karol Marcinkowski University of Medical Sciences, Poznań, Poland.
Biol Trace Elem Res. 2000 Jan;73(1):55-65. doi: 10.1385/BTER:73:1:55.
The relationships among concentrations of copper and zinc, the oxidase activity of ceruloplasmin (Cp) in serum, and Cu,Zn-SOD (superoxide dismutase) activity in erythrocytes were investigated in men with atherosclerosis obliterans (AO) and a control group. The oxidase activity of Cp was measured with o-dianisidine dihydrochloride as a substrate, and Cu,Zn-SOD activity in erythrocytes by using the RANSOD kit. The lipid profile and uric acid concentration were determined in AO and control groups. The results showed higher copper and zinc concentrations in serum in the AO group (20.0+/-3.5 and 18.0+/-3.2 micromol/L, respectively) in comparison with the control group (15.6+/-2.3 and 14.7+/-1.9 micromol/L). The Cp activity in serum was higher in the AO group (174.2+/-61.8 U/L) than in the control group (93.7+/-33.9 U/L), and a significant difference was found in the activity of Cu,Zn-SOD in erythrocytes (2389+/-1396 and 1245+/-365 U/g Hb, respectively) between both groups. The activity of Cu,Zn-SOD was positively correlated with copper in the control group (r=0.73), but not in AO, and negatively with uric acid concentration (r= -0.63) in the AO group. The oxidase activity of Cp was correlated with copper, but not zinc, in AO and control groups (r> or =0.65). Negative correlation coefficients were calculated for uric acid and copper and zinc concentrations in the AO group (-r > or = 0.61). Increased copper concentrations and oxidase activity of Cp in serum in AO and the activity of Cu,Zn-SOD in erythrocytes could result from atherosclerotic disease, accompanied by chronic ischemia of a lower limb. These results suggest also that relationship between copper concentration and Cu,Zn-SOD activity in erythrocytes found in the serum of healthy subjects may be disturbed in pathologic conditions.
在患有闭塞性动脉硬化症(AO)的男性和一个对照组中,研究了血清中铜和锌的浓度、铜蓝蛋白(Cp)的氧化酶活性以及红细胞中铜锌超氧化物歧化酶(Cu,Zn-SOD)活性之间的关系。以盐酸邻联茴香胺为底物测定Cp的氧化酶活性,使用RANSOD试剂盒测定红细胞中的Cu,Zn-SOD活性。测定AO组和对照组的血脂谱和尿酸浓度。结果显示,AO组血清中的铜和锌浓度(分别为20.0±3.5和18.0±3.2微摩尔/升)高于对照组(15.6±2.3和14.7±1.9微摩尔/升)。AO组血清中的Cp活性(174.2±61.8 U/L)高于对照组(93.7±33.9 U/L),两组红细胞中Cu,Zn-SOD的活性存在显著差异(分别为2389±1396和1245±365 U/g Hb)。对照组中Cu,Zn-SOD的活性与铜呈正相关(r = 0.73),但在AO组中并非如此,且在AO组中与尿酸浓度呈负相关(r = -0.63)。在AO组和对照组中,Cp的氧化酶活性与铜相关,但与锌无关(r≥0.65)。计算得出AO组中尿酸与铜和锌浓度的负相关系数(-r≥0.61)。AO患者血清中铜浓度升高、Cp氧化酶活性以及红细胞中Cu,Zn-SOD活性升高可能是由动脉粥样硬化疾病导致的,伴有下肢慢性缺血。这些结果还表明,健康受试者血清中发现的铜浓度与红细胞中Cu,Zn-SOD活性之间的关系在病理条件下可能会受到干扰。